Melissa Allen, MD
Obstetrics & Gynecology · New Albany, INNPI 1386784320
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $745, 4.7 times the $159 reported in 2019.
Across 104 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$349
- Biogen$329
- Sumitomo Pharma America, Inc.$173
- AbbVie$128
- Aspira Women's Health Inc$115
- Mayne Pharma Commercial LLC$86
- plus $862 from 23 others
What the payments were for
- Food & beverage$2,042100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 19 | $349 |
| Biogen | 13 | $329 |
| Sumitomo Pharma America, Inc. | 9 | $173 |
| AbbVie | 7 | $128 |
| Aspira Women's Health Inc | 2 | $115 |
| Mayne Pharma Commercial LLC | 5 | $86 |
| Bayer | 6 | $79 |
| Hologic Sales And Service, LLC | 2 | $77 |
| Shield Therapeutics Inc | 1 | $70 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Merck | 4 | $52 |
| Organon | 4 | $49 |
| Novo Nordisk | 3 | $48 |
| Pfizer | 3 | $47 |
| Exeltis, USA Inc. | 3 | $44 |
| Pharmacosmos Therapeutics Inc. | 2 | $39 |
| Radius Health, Inc. | 2 | $30 |
| Pacira Pharmaceuticals Incorporated | 2 | $30 |
| Coopersurgical, Inc. | 2 | $29 |
| Millicent US Inc | 2 | $28 |
| Amgen | 2 | $27 |
| Lupin Inc. | 1 | $27 |
| Vertex | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Medline Industries LP | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Organogenesis Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
How this compares
$2,042 in reported general payments places this provider in the 75th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Norethindrone | 12 | $103 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New Albany
- Stephen BaldwinNew Albany$6K
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
- Enrique InfanteElkhart$41K
- Paul MorrisonNewburgh$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.